Status:
ACTIVE_NOT_RECRUITING
Predicting Chemo Toxicity Using Geriatric Forms
Lead Sponsor:
Çanakkale Onsekiz Mart University
Conditions:
Oncology
Geriatric Oncology
Eligibility:
All Genders
65+ years
Brief Summary
This prospective observational study aims to evaluate and compare the effectiveness of three geriatric assessment tools-CARG (Cancer and Aging Research Group score), G8 screening tool, and Frailty Sca...
Eligibility Criteria
Inclusion
- Patients aged 65 years or older.
- Histologically confirmed cancer diagnosis with a pre-planned chemotherapy regimen (adjuvant, neoadjuvant, or palliative intent).
- Chemotherapy not yet initiated at the time of enrollment.
- Clinically stable condition, as assessed by the oncologist.
- Willingness and ability to provide written informed consent.
Exclusion
- Presence of acute infection or advanced organ failure (cardiac, hepatic, or renal).
- Severe psychiatric illness or cognitive impairment that interferes with the ability to complete assessments.
- Patients receiving concurrent hormonal therapy, targeted therapy, immunotherapy, or radiotherapy.
- Diagnosis of hematologic malignancies (e.g., leukemia, lymphoma, myeloma).
Key Trial Info
Start Date :
December 10 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 20 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT07163169
Start Date
December 10 2024
End Date
December 20 2026
Last Update
September 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Çanakkale Onsekiz Mart Univercity
Çanakkale, Turkey (Türkiye), 17020